XCL1-based vaccibodies (pantec Biosolutions AG)

N/A

Report date: 2025/03/20 14:37:36
NME

Base Information

Drug NameXCL1-based vaccibodies (pantec Biosolutions AG)
Drug Alias NameXCL1-OVA vaccibodies
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryLiechtenstein
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPantec Biosolutions Ag
China Registration ClassN/A

Develop Information

Active CompaniesPantec Biosolutions Ag
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A